Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) is currently trading at 104.25 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Aarey Drugs & Pharmaceuticals Ltd, founded in 1990, manufactures and supplies pharmaceutical raw materials, chemicals, and API drugs. The company underwent a significant transition in 1993 when the Aarey Group took over and rebranded the company from Niharika Textiles & Chemicals. Aarey Drugs produces pharmaceutical products compliant with IP/BP/CP/USP standards, indicating high-quality assurance and adherence to international regulatory standards. In 2009 and 2016, the company upgraded and diversified its manufacturing capabilities, including new products like Mono Methyl Urea and Erithromycin Derivatives.

Over the past 52 weeks, Aarey Drugs & Pharmaceuticals Ltd has traded between a low of ₹50.40 and a high of ₹118.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Aarey Drugs & Pharmaceuticals Ltd has a market capitalization of approximately 337.71. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Aarey Drugs & Pharmaceuticals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 80.99 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 337.71 Cr, Aarey Drugs & Pharmaceuticals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Aarey Drugs & Pharmaceuticals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Aarey Drugs & Pharmaceuticals Ltd is 80.99. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.